Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter and nine months ended December 31, 2023.01-02-2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter and nine months ended December 31, 2023.Thyrocare Technologies Ltd - 539871 - For The Quarter And Nine Months Ended December 31, 2023
Financial Results for the quarter and nine months ended December 31, 2023.Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for For Financial Results For The Quarter And Nine Months Ended December 31, 2023
1. the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2023. 2. appointment of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the Company w.e.f. February 01, 2024;Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisition
We wish to inform you that Thyrocare Technologies Limited has entered into Share Purchase Agreement with Think Health Diagnostics Private Limited and existing shareholders of Think Health on February 1, 2024 at 12:30 pm (IST) to acquire 100% stake in Think Health from all the existing shareholders of Think Health.Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor call intimationThyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2023.
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 ,inter alia, to consider and approve Board meeting intimation for Approval of The Unaudited Financial Results of The Company For The Quarter And Nine Months Ended 31St December 2023.Thyrocare Technologies Ltd - 539871 - Intimation For Appointment Of Mr. Rahul Guha, Managing Director And Chief Executive Officer Of The Company As President - Operations And Designated As Key Managerial Personnel Of API Holdings Limited, Ultimate Holding Company
Appointment of Mr. Rahul Guha as Key Managerial personnel of API Holdings LimitedThyrocare Technologies Ltd - 539871 - Closure of Trading Window
This is to to inform you that the Trading Window will be closed for dealing in securities of the Company by Designated Persons of the Company from January 01, 2024 and shall be remain closed upto 48 hours after declaration of the Financial Results for the Quarter ending December 31, 2023.Thyrocare Technologies share price may see 20% upside; ICICI Securities upgrades stock, raises target price
ICICI Securities has upgraded Thyrocare Technologies stock to Buy' from Add; earlier and raised the target price to 740 per share from 615.Buy Thyrocare Technologies; target of Rs 740: ICICI Securities
ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.